NightBalance Receives Coverage From Largest Dutch Healthcare Payor Achmea For Innovative Sleep Position Trainer To Prevent Obstructive Sleep Apnea
• Sleep Position Trainer is world’s first innovative apnea device to be reimbursed by a major healthcare payor
• NightBalance to raise series B financing to support further commercial roll-out of SPT and obtain U.S. FDA 510(k) approval
Delft, the Netherlands, May 18, 2015 / B3C newswire / -- NightBalance BV, a leading innovator of obstructive sleep apnea (OSA) technology, announced today that Achmea, the largest healthcare payor in the Netherlands covering 5 million lives, will reimburse its Sleep Position Trainer (SPT). This makes the SPT, which is CE marked since January 1, 2012, the first innovative OSA device in the world to be reimbursed. Since the commercial launch in early 2012, NightBalance currently sells the SPT in 11 European countries through its network of specialized distributors.
Achmea has designated the SPT as a first-line treatment for apnea. The SPT is a smart device that gently trains patients not to sleep on their back (supine) to prevent apnea. Alternative treatment modalities such as continuous positive airway pressure (CPAP) or the use of a mandibular advancement devices (MAD) are considered effective, but invasive, uncomfortable, and complex. NightBalance has accumulated a wealth of clinical data demonstrating the efficacy and ease of use of its sleep position trainer, and a substantial increase in patient compliance.
NightBalance intends to raise a series B financing to support the further international commercial roll-out of the SPT, obtain reimbursement in other markets, and conduct studies to obtain 510(k) clearance from the U.S. FDA.
Help employers find you! Check out all the jobs and post your resume.
• NightBalance to raise series B financing to support further commercial roll-out of SPT and obtain U.S. FDA 510(k) approval
Delft, the Netherlands, May 18, 2015 / B3C newswire / -- NightBalance BV, a leading innovator of obstructive sleep apnea (OSA) technology, announced today that Achmea, the largest healthcare payor in the Netherlands covering 5 million lives, will reimburse its Sleep Position Trainer (SPT). This makes the SPT, which is CE marked since January 1, 2012, the first innovative OSA device in the world to be reimbursed. Since the commercial launch in early 2012, NightBalance currently sells the SPT in 11 European countries through its network of specialized distributors.
Achmea has designated the SPT as a first-line treatment for apnea. The SPT is a smart device that gently trains patients not to sleep on their back (supine) to prevent apnea. Alternative treatment modalities such as continuous positive airway pressure (CPAP) or the use of a mandibular advancement devices (MAD) are considered effective, but invasive, uncomfortable, and complex. NightBalance has accumulated a wealth of clinical data demonstrating the efficacy and ease of use of its sleep position trainer, and a substantial increase in patient compliance.
NightBalance intends to raise a series B financing to support the further international commercial roll-out of the SPT, obtain reimbursement in other markets, and conduct studies to obtain 510(k) clearance from the U.S. FDA.
Help employers find you! Check out all the jobs and post your resume.